1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Pharyngeal Neoplasm Global Clinical Trials Review, H1, 2015

Pharyngeal Neoplasm Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Pharyngeal Neoplasm Global Clinical Trials Review, H1, 2015" provides data on the Pharyngeal Neoplasm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pharyngeal Neoplasm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pharyngeal Neoplasm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Pharyngeal Neoplasm Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Pharyngeal Neoplasm 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Pharyngeal Neoplasm 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Pharyngeal Neoplasm Therapeutics Clinical Trials 33
Prominent Drugs 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Sanofi 36
Clinical Trial Overview of Sanofi 36
F. Hoffmann-La Roche Ltd. 37
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 37
E. Merck KG 38
Clinical Trial Overview of E. Merck KG 38
C. H. Boehringer Sohn AG and Co. KG 39
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 39
GlaxoSmithKline plc 40
Clinical Trial Overview of GlaxoSmithKline plc 40
Merck and Co., Inc. 41
Clinical Trial Overview of Merck and Co., Inc. 41
Oncolytics Biotech Inc. 42
Clinical Trial Overview of Oncolytics Biotech Inc. 42
Celgene Corporation 43
Clinical Trial Overview of Celgene Corporation 43
Bristol-Myers Squibb Company 44
Clinical Trial Overview of Bristol-Myers Squibb Company 44
Clinical Trial Overview of Top Institutes / Government 45
National Cancer Institute 45
Clinical Trial Overview of National Cancer Institute 45
Sun Yat-sen University 50
Clinical Trial Overview of Sun Yat-sen University 50
Baylor College of Medicine 52
Clinical Trial Overview of Baylor College of Medicine 52
Radiation Therapy Oncology Group 53
Clinical Trial Overview of Radiation Therapy Oncology Group 53
Sun Yat-Sen University Cancer Center 54
Clinical Trial Overview of Sun Yat-Sen University Cancer Center 54
Chinese University of Hong Kong 55
Clinical Trial Overview of Chinese University of Hong Kong 55
FUDAN University 56
Clinical Trial Overview of FUDAN University 56
Memorial Sloan Kettering Cancer Center 57
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 57
European Organization for Research and Treatment of Cancer 58
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 58
Five Key Clinical Profiles 59
Appendix 93
Abbreviations 93
Definitions 93
Research Methodology 94
Secondary Research 94
About GlobalData 95
Contact Us 95
Disclaimer 95
Source 95

List of Tables
Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Region, 2015* 7
Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Pharyngeal Neoplasm Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Pharyngeal Neoplasm Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Pharyngeal Neoplasm Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Pharyngeal Neoplasm Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Pharyngeal Neoplasm Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Pharyngeal Neoplasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Pharyngeal Neoplasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Pharyngeal Neoplasm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Pharyngeal Neoplasm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Pharyngeal Neoplasm Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Pharyngeal Neoplasm Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Pharyngeal Neoplasm Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
Pharyngeal Neoplasm Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31
Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 34
Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 35
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 36
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 37
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015* 38
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2015* 39
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 40
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 41
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncolytics Biotech Inc., 2015* 42
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015* 43
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 44
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 45
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 50
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015* 52
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2015* 53
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-Sen University Cancer Center, 2015* 54
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 55
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2015* 56
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 57
Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 58

List of Figures
Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Pharyngeal Neoplasm Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Pharyngeal Neoplasm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Pharyngeal Neoplasm Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Pharyngeal Neoplasm Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Pharyngeal Neoplasm Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Pharyngeal Neoplasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Pharyngeal Neoplasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Pharyngeal Neoplasm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Pharyngeal Neoplasm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
Pharyngeal Neoplasm Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31
Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 35
GlobalData Methodology 94

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.